NVision

NVision is a quantum technology company for healthcare. From its funding announcement.

$55M Series BRaised 5 months agoUlm, GermanyHealthcare & MedtechGermany
Visit website →

In their own words

What NVision says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "quantum technology company for healthcare". Source

Why now

Where NVision is today

NVision announced a Series B round of $55M on 13 May 2026, led by Abbott.

Latest round
Series B
Amount
$55M
Announced
13 May 2026
Headquarters
Ulm, Germany
Sector
Healthcare & Medtech
Investors
Also participating
Playground Global, Matterwave/b2ventures, Entrée Capital
Lender
Relevant leadership
CEO Sella Brosh

Momentum AfterRaise intelligence

AfterRaise Score

55
Steady growth
0 funding signals in the last 90 days
Funding recency
18/40
announced within the last 6 months
Round scale
19/25
round size relative to the market
Funding stage
18/20
Series B
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 13 May 2026
    $55M Series B
    Led by Abbott.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Accelerated hiring across functions
  • Commercial scale-up
  • New market preparation
  • Leadership team completion

Opportunities this could create

  • Clinical evidence
  • Regulatory affairs
  • Reimbursement and market access
  • Hospital procurement experience
  • Quality systems

Based on the Healthcare & Medtech sector and a Series B round. Not a statement of fact.

Early momentum1 connected signal
  • 13 May 2026$55M Series B announced

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What NVision is open to

Not yet specified

NVision has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with NVision

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at NVision?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: what the round is for, in your words and the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Healthcare & Medtech companies

See the sector